A Global Pioneer to Detect Amyloid-β(Aβ) by Urine

A Global Pioneer to Detect Amyloid-β(Aβ) by Urine

MORE +

湖南乾康科技有限公司

MORE +
scroll down

One Step Dementia Risk Test Kit

Sensivity 75.7%,Specificity 91.03%

First Globally

Clinically approved

Accurate

Non-invasive

Fast: 10 Mins have the result

Learn More

One Step Dementia Risk Test Kit

Sensivity 75.7%,Specificity 91.03%

First Globally

Clinically approved

Accurate

Non-invasive

Fast: 10 Mins have the result

Learn More

One Step Dementia Risk Test Kit

Sensivity 75.7%,Specificity 91.03%

First Globally

Clinically approved

Accurate

Non-invasive

Fast: 10 Mins have the result

Learn More

One Step Dementia Risk Test Kit

One Step Dementia Risk Test Kit

One Step Dementia Risk Test Kit

One Step Dementia Risk Test Kit
One Step Dementia Risk Test Kit
One Step Dementia Risk Test Kit

One Step Dementia Risk Test Kit

Sensivity 75.7%,Specificity 91.03%

First Globally

Clinically approved

Accurate

Non-invasive

Fast: 10 Mins have the result

View Details
  • International scientific research team
    International scientific research team
    Many researchers, including Professor Baijun Gu Qankorey Life Science R&D Center, Chief Scientist of Qankorey Technology, and Colin Masters, Chief Scientific Advisor of Qankorey Technology.
  • Qankorey Life Science R&D Center
    Qankorey Life International R & D Center
    Including the Qankorey Life Science (Changsha) R&D Center and Qankorey Life Science (Melbourne) Research Center, we provide comprehensive solutions for the prevention, screening, diagnosis, and treatment of Alzheimer's disease.
  • Industry-university-research cooperation
    Industry-university-research cooperation
    We have established cooperation with AIBL and Florey research institutes abroad, as well as with various research institutes and hospitals such as Huashan Hospital and Ruijin Hospital of Fudan University in China.
  • Qualifications and Patents
    Qualifications and Patents
    Undertaking more than ten major special projects of the Ministry of Science and Technology and provincial and municipal governments, possessing more than 160 intellectual property rights such as patents and software copyrights.

  • R&D and Manufacturing
    A biotechnology enterprise that focuses on the research of key technologies for Alzheimer's disease (AD), a global medical challenge. It provides full industry chain services in research and development, production, and sales, achieving full process management of Alzheimer's disease.
    View More

    Globalization Development

    Speed up the internationalization strategy and create a new pattern in the AD market.

    The business has spread across Asia, Europe, North America, Oceania, Africa and other places. It is continuously enhancing brand influence and steadily advancing the international marketing strategy.

    Join us
    Hunan Qankorey Biotechnology Co.,Ltd.

    News And Events

    Enterprise dynamics